Stay updated on RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference2%
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check69 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check83 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a study evaluating the efficacy and safety of intravenous RC48-ADC for urothelial carcinoma, including inclusion and exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference30%
Stay in the know with updates to RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.